Avertissement: Ce site agrège des données publiques officielles provenant de la FDA, ClinicalTrials.gov, PubMed et SEC EDGAR à titre de référence générale uniquement. Il ne constitue pas un avis médical, un diagnostic, une recommandation de traitement ni un conseil en investissement.

PubMed

Review of successful pathways for regulatory approvals in open-field fluorescence-guided surgery.

PMID : 33715318 · 2021

B, r, i, a, n, , W, , P, o, g, u, e, ;, , E, b, e, n, , L, , R, o, s, e, n, t, h, a, l

RevueJournal of biomedical optics
Année2021
PMID33715318

Résumé

The modern use of fluorescence in surgery came iteratively through new devices and pre-existing imaging agents, with indications that were paved via regulatory approvals and device clearances. These events led to a growing set of surgery subspecialty uses. This article outlines the key milestones that initiated commercially marketed systems and agents by highlighting temporal sequences and strategic decisions between them, with the goal of helping to inform future successes. A review of successf

Source officielle

Voir sur PubMed →

Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.

↑